Suspension of trading
Lords & Company Worldwide Holdings Inc. Stock Canadian Securities Exchange
Stocks
LRDS
CA54404Q2009
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CAD | -.--% |
|
-.--% | - |
| Market Cap | 94.9K 83.11K 76.71K 70.87K 134K 9.07M 137K 919K 358K 4.45M 356K 349K 15.43M | P/E 2021 |
-1.31x | P/E 2022 | -0.72x |
|---|---|---|---|---|---|
| Enterprise Value | -59.11K -51.77K -47.78K -44.14K -83.74K -5.65M -85.27K -573K -223K -2.77M -222K -217K -9.61M | EV / Sales 2021 |
-
| EV / Sales 2022 | 459,754x |
| Free-Float |
99.84% | Yield 2021 * |
-
| Yield 2022 | - |
| 5 years | 0 | 1.5 | |
| 10 years | 0 | 7.2 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 57 | ||
| +0.04% | +2.74% | -12.50% | -6.44% | 12.77B | ||
| +1.34% | +1.25% | -34.12% | -56.33% | 4.66B | ||
| +0.15% | +3.59% | -8.37% | -4.43% | 4.41B | ||
| +1.14% | +7.42% | +23.09% | -2.44% | 3.86B | ||
| +0.52% | +2.53% | +5.41% | -38.18% | 3.76B | ||
| +0.21% | +6.27% | -11.68% | +2.48% | 3.08B | ||
| +3.03% | +7.21% | -7.90% | -13.49% | 3.13B | ||
| +3.96% | +7.88% | -4.95% | -21.76% | 2.35B | ||
| +2.10% | +13.00% | -6.89% | +44.84% | 1.78B | ||
| Average | +1.25% | +2.23% | -6.43% | -10.64% | 4.42B | |
| Weighted average by Cap. | +0.93% | +1.29% | -8.31% | -13.15% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | 2.84 2.49 2.3 2.12 4.03 271.6 4.1 27.54 10.72 133.18 10.67 10.44 462.1 |
| Net income | -3.26M -2.85M -2.63M -2.43M -4.61M -311M -4.7M -31.55M -12.28M -153M -12.22M -11.96M -529M | -1.47M -1.29M -1.19M -1.1M -2.08M -140M -2.12M -14.22M -5.53M -68.78M -5.51M -5.39M -239M |
| Net Debt | -4.53K -3.97K -3.66K -3.39K -6.42K -433K -6.54K -43.91K -17.09K -212K -17.01K -16.65K -737K | -154K -135K -124K -115K -218K -14.72M -222K -1.49M -581K -7.22M -578K -566K -25.04M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LRDSF Stock
- LRDS Stock
Select your edition
All financial news and data tailored to specific country editions
















